1599-5453 Contact Us KO
Diagnostic Tools

Heart Rate Variability (HRV)

HRV

Heart rate variability (HRV) measures the variation in time intervals between consecutive heartbeats, serving as a non-invasive biomarker of autonomic nervous system function and overall cardiovascular health.

2026-03-27

At a Glance

HRV analysis quantifies beat-to-beat variability in R-R intervals, reflecting the dynamic interplay between sympathetic and parasympathetic nervous systems. Higher HRV generally indicates better autonomic flexibility and cardiovascular health. Key metrics include SDNN (overall variability), RMSSD (parasympathetic activity), and LF/HF ratio (sympathovagal balance). Low HRV is associated with increased cardiovascular mortality, depression, and autonomic neuropathy. Clinical applications include dysautonomia assessment, post-MI risk stratification, and treatment monitoring.

Definition and Overview

Heart rate variability (HRV) is the physiological variation in time intervals between consecutive heartbeats (R-R intervals). It reflects the dynamic interplay between the sympathetic and parasympathetic divisions of the autonomic nervous system and serves as a non-invasive biomarker of autonomic function [1].

Higher HRV generally indicates greater autonomic flexibility, better cardiovascular health, and greater stress resilience. Reduced HRV is associated with increased cardiovascular mortality, autonomic neuropathy, depression, and various chronic diseases [2].

Test Parameters

Time Domain Measures

  • SDNN (standard deviation of NN intervals): reflects overall autonomic variability; normal 100-200 ms for 24-hour recording
  • RMSSD (root mean square of successive differences): primarily reflects parasympathetic activity; normal >20 ms
  • pNN50: percentage of successive NN intervals differing by >50 ms; parasympathetic marker

Frequency Domain Measures

  • HF (high frequency, 0.15-0.4 Hz): parasympathetic (vagal) activity marker
  • LF (low frequency, 0.04-0.15 Hz): mixed sympathetic and parasympathetic influences
  • LF/HF ratio: sympathovagal balance indicator (controversial interpretation)
  • VLF (very low frequency, 0.003-0.04 Hz): thermoregulation and RAAS influences

Testing Methods

Short-term HRV recording (5 minutes) in a standardized resting position is the most common clinical method. 24-hour Holter monitoring provides time-domain analysis including SDNN. ECG-based measurement ensures highest accuracy [3].

Wearable devices (photoplethysmography-based) offer convenient but less precise HRV monitoring suitable for tracking trends over time.

Clinical Applications

Dysautonomia assessment: reduced HRV confirms autonomic dysfunction in POTS, diabetic autonomic neuropathy, and Parkinson's disease [1].

Cardiovascular risk: low SDNN (<50 ms) post-myocardial infarction predicts increased mortality risk [2].

Mental health: depression and anxiety consistently show reduced HRV, particularly decreased RMSSD and HF power.

Treatment monitoring: HRV improvement tracks response to exercise training, medication, and autonomic rehabilitation.

Factors Affecting HRV

  • Age: HRV naturally decreases with age
  • Exercise: regular aerobic training increases HRV
  • Stress: chronic stress reduces HRV
  • Sleep: HRV is highest during deep sleep
  • Medications: beta-blockers increase HRV; anticholinergics decrease it
  • Breathing: slow deep breathing (6 breaths/minute) maximizes HRV

Improving HRV

Regular aerobic exercise (150 minutes/week) is the most effective intervention for improving HRV. Slow-paced breathing (resonance frequency breathing at 6 breaths/min), meditation, and adequate sleep (7-9 hours) also enhance vagal tone. Reducing alcohol, maintaining healthy weight, and managing chronic stress contribute to HRV optimization [4].

Frequently Asked Questions

FAQ content is being prepared.

References

  1. [1] Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996). "Heart rate variability: standards of measurement, physiological interpretation and clinical use." Circulation, 93: 1043-1065. DOI PubMed
  2. [2] Shaffer F, Ginsberg JP (2017). "An overview of heart rate variability metrics and norms." Frontiers in Public Health, 5: 258. DOI PubMed
  3. [3] Thayer JF, Yamamoto SS, Brosschot JF (2010). "The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors." International Journal of Cardiology, 141: 122-131. DOI PubMed
  4. [4] Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ (1987). "Decreased heart rate variability and its association with increased mortality after acute myocardial infarction." American Journal of Cardiology, 59: 256-262. DOI PubMed
  5. [5] Laborde S, Mosley E, Thayer JF (2017). "Heart rate variability and cardiac vagal tone in psychophysiological research – recommendations for experiment planning, data analysis, and data reporting." Frontiers in Psychology, 8: 213. DOI PubMed
  6. [6] Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D (1994). "Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study." Circulation, 90: 878-883. DOI PubMed

Related Articles

Exercise and the Autonomic Nervous System Parasympathetic Nervous System
HRVheart rate variabilitySDNNRMSSDautonomic balancecardiovascular health

This content is provided for medical informational purposes only and cannot replace professional medical advice. If you have symptoms, please consult a specialist.

Are you concerned about related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.

02-514-8887 Contact Us